Joinn Laboratories(China)Co.,Ltd.
603127
Kedudukan dalam Saham
#3819
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Harga Saham
$6.82
Modal Pasaran
$4.30B
Perubahan (1 hari)
-6.30%
Perubahan (1 tahun)
48.79%
Negara
CN
Perdagangan Joinn Laboratories(China)Co.,Ltd. (603127)
Kategori
Healthcare
Pendapatan untuk Joinn Laboratories(China)Co.,Ltd. (603127)
Pendapatan pada Jun 2026 TTM: $160.62M
Menurut laporan kewangan terkini Joinn Laboratories(China)Co.,Ltd., pendapatan semasa syarikat ialah $160.62M. Pada tahun 2024, syarikat memperoleh pendapatan sebanyak $14.25M, penurunan berbanding pendapatan pada tahun 2023 yang berjumlah $71.62M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Joinn Laboratories(China)Co.,Ltd. dari 2012 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $160.62M | 232.97% |
| 2025 | $48.24M | 238.43% |
| 2024 | $14.25M | -80.10% |
| 2023 | $71.62M | -60.16% |
| 2022 | $179.77M | 77.97% |
| 2021 | $101.01M | 83.00% |
| 2020 | $55.19M | 78.38% |
| 2019 | $30.94M | 66.47% |
| 2018 | $18.59M | 29.46% |
| 2017 | $14.36M | 63.39% |
| 2016 | $8.79M | -1.08% |
| 2015 | $8.88M | -12.00% |
| 2014 | $10.09M | 132.26% |
| 2013 | $4.35M | 289.26% |
| 2012 | $1.12M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $7.87B | 4,799.19% |
US
|
|
| $4.82B | 2,899.66% |
US
|
|
| $-252.70M | -257.33% |
US
|
|
| $4.12B | 2,465.46% |
CN
|
|
| $1.66B | 932.26% |
US
|
